Page 45 - GPD-2-3
P. 45

Gene & Protein in Disease                                               Effect of phytochemicals in diabetes




            Table 8. The binding energy of docking interaction between   3.4.2. AMPK2 targets interaction with leads and
            AMPK1 target and ligands (control and test compounds)  control compounds
            Group   Docked compound    Binding energy (kcal/mol)  Interaction between AMPK2 (chain A, pocket residues
            Control  AMPK1–metformin           −4.0            Glu264) and metformin is established and confirmed by
            Test    AMPK1–vindolinine          −7.4            docking pose in  Figure  2A. Metformin is attached with
                                                               AMPK2 residues Asp261, His247, and Thr243 through four
                    AMPK1–vindoline            −6.3            usual H-bond interactions of 2.33 Å, 2.11 Å, 2.40 Å, and
                    AMPK1–(+)-vindorosine      −6.3            2.40 Å; a carbon H-bond relations with residues Asp261 of
                    AMPK1–Cr-1                 −6.4            3.54Å; and two attractive charge interactions of 4.45 Å and
                    AMPK1–Cr-2                 −6.1            5.18 Å with Asp261 residues (Table S2). The Vina score of
                                                               binding affinity between them is −4.2 kcal/mol (Table 9).
            forms a π-alkyl interaction of 5.47 Å between the target   Vindoline (CID: 425978) interacts through chain A
            and the lead (Table S1).                           residue GLU264 of the AMPK2 and binding is confirmed by
                                                               molecular docked pose (Figure 2B). The potential binding
              The molecular docked pose of (+)-vindorosine
            (CID: 261578) and AMPK1 (Figure 1D) showed that the   energy between vindoline and AMPK2 is −6.2 kcal/mol
            lead attaches within a selected pocket site (residue Arg199)   (Table 9). The lead is connected with AMPK2 residues
                                                               with non-covalent interaction, such as Arg263 forms two
            of AMPK1 chain A through non-covalent interactions and   H-bond of 2.21 Å and 2.29 Å; Lys260 and Arg263 residues
            has a binding affinity of –6.3 kcal/mol. There is one intra-  form two carbon H-bond connections of 2.62 Å and 2.80
            molecular conventional H-bond interaction of 2.08 Å; a   Å, respectively; residues Leu272 and Arg263 interact with
            π-σ interaction with Phe180 residues of 3.5 Å; a π-alkyl   two alkyl connections of 5.22 Å and 3.87 Å, respectively;
            interaction of 4.48 Å with a Phe180 residue; and an alkyl   residues Glu279 by an attractive charge interaction of 5.36
            interaction with Leu200 residues of 4.61 Å (Table S1).
                                                               Å; and residues Asp280 with an unfavorable acceptor-
              The docking pose (Figure 1E) reveals that the binding   acceptor interaction of 2.97 Å (Table S2).
            of Cr-1 (CID: 5315746) around Arg199 residues of chain A   The potential energy of binding (−5.6 kcal/mol)
            of AMPK1 through non-covalent links and had a binding   and conformer docked pose (Figure  2C) of vindolinine
            affinity of −6.4 kcal/mol. There are two conventional   (CID: 24148538) and AMPK2 chain A, pocket residue Glu264,
            H-bond interactions with Gly198 and Arg182 of 1.95   establishes the presence of stable molecular interaction
            Å  and 2.57  Å,  respectively;  three  carbon  H-bonds  with   between them. There is one carbon H-bond interaction
            Ser197, Gly198, and Gln464 of 3.54 Å, 3.67 Å, and 3.37 Å,   with target residue Glu264 of 3.45 Å; two attractive charge
            respectively; an intramolecular π-σ interaction of 3.69 Å;   interactions with Glu264 and Asp280 of 4.77 Å and 5.16 Å,
            two alkyl interactions with Arg199 and Leu200 of 4.42 Å   respectively; a single  π-anion interaction with Asp280 of
            and 4.44 Å, respectively; and a unfavorable positive-  3.95Å; a single π-cation interaction with Lys269 of 3.97 Å;
            positive interaction with Arg199 of 4.11Å (Table S1).  and one π-alkyl interaction with Arg263 between the target
              Figure 1F shows the binding of Cr-2 (CID: 59908094) in   residues and the lead of 5.36 Å length (Table S2).
            the active site pocket residue Arg199 of chain A of AMPK1.   The lead compound (+)-vindorosine (CID:261578)
            The complex molecular docked pose shows interactions   and AMPK2 interaction docked pose (Figure  2D) has
            between them like two π-σ interactions through Tyr463   established that the compound positively enters and
            and Phe180 of 3.51 Å and 3.55 Å, respectively; single   connected to the catalytic site Glu264 residue of chain A of
            π-alkyl interaction with Tyr463 of 4.25 Å; and one alkyl   AMPK2, with 3 conventional H-bond interaction around
            interaction  through  Leu200  of  5.28  Å.  The  minimum   catalytic pocket residues Arg263 of 2.10Å, 2.41 Å, and
            potential binding energy between them is −6.1 kcal/mol   3.0 Å; one carbon H-bond interaction through Glu264 of
            (Table S1).                                        3.65 Å; two alkyl interactions through Lys260 of 4.17 Å and
              The potential binding energy or binding affinity value   3.77 Å; single attractive charge interaction with Glu264 of
            of a lead compound with AMPK1 extends between      4.62 Å; and a single π-anion bond contact with Glu279 of
            −7.4 and −6.1 kcal/mol whereas AMPK1 and metformin   3.86 Å. The minimum potential energy for binding between
            are −4.0 kcal/mol (Table 8). The results support the fact that   (+)-vindorosine and AMPK2 is −5.6 kcal/mol (Table S2).
            the aforementioned compounds have lower free energy of   The docked pose at the molecular level (Figure  2E)
            interaction than the control drug and the biomolecules can   of AMPK2 and lead Cr-1 (CID: 5315746) has confirmed
            become a potent AMPK1 stimulator.                  about definite interaction between them and the compound



            Volume 2 Issue 3 (2023)                         7                        https://doi.org/10.36922/gpd.0927
   40   41   42   43   44   45   46   47   48   49   50